Results 141 to 150 of about 234,309 (195)

Concurrent cervical and extra cervical HPV-related lesions: an observational study. [PDF]

Eur J Clin Microbiol Infect Dis
Palaia I, Cavallari EN, Tanzi F, Pierangeli A, Ralli M, Meliante PG, Clementi I, Di Donato V, Perniola G, Pernazza A, Palaia G, Investigators of the H. P. V. Unit.   +11 more
europepmc   +1 more source

Local immunosuppressive microenvironment underlies reduced responsiveness to imiquimod treatment in recurrent or residual cervical HSIL. [PDF]

Gynecol Oncol Rep
Muntinga CLP, Sande AJV, Welters MJP, Kooreman LFS, Bekkers RLM, Beekhuizen HV, Burg SHV, Steenwijk PJVV, Esch EMGV.   +8 more
europepmc   +1 more source

Inhibition of Plasminogen Activator Inhibitor-1 (PAI-1) by Tiplaxtinin Attenuates the Aggressive Phenotype of Vulvar Squamous Cell Carcinoma Cells <i>In Vitro</i>. [PDF]

In Vivo
Warmbold J, Gallwas J, Gründker C.
europepmc   +1 more source

Noninvasive physical plasma in vulvar lichen sclerosus: a prospective pilot study. [PDF]

Int J Womens Dermatol
Schröder C, Feodorovici K, Tascón Padrón L, Otten LA, Stope MB, Mustea A.   +5 more
europepmc   +1 more source

Application of Cobas 6800 HPV testing and qPCR utilizing three genomically-optimized primer sets for detecting HPV DNA in the blood of HPV Positive dysplasia and cancer patients. [PDF]

PLoS One
Mostafa HH, Fall A, Gaillard S, Fakhry C, Khan Z, Seiwert T, Wang H, Tsai HL, Fader AN, Leath CA, Huh WK, Arend RC, Tsai YC, Califano JA, Xing D, Wu TC, Roden RBS.   +16 more
europepmc   +1 more source

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trial. [PDF]

Int J Cancer
Stankiewicz Karita HC, Magaret AS, Doody DR, Schouten JT, Mao C, Huh WK, Grieco VS, Seymour MA, Varon D, Shrader KH, Xi LF, Galloway DA, Wald A, Madeleine MM.   +13 more
europepmc   +1 more source

Vulvar intraepithelial neoplasia: Incidence and long-term risk of vulvar squamous cell carcinoma [PDF]

International Journal of Cancer, 2021
The risk of vulvar squamous cell carcinoma (VSCC) in patients with high-grade vulvar intraepithelial neoplasia (VIN) is considered lower in high-grade squamous intraepithelial lesion (HSIL) compared to differentiated VIN (dVIN), but studies are limited ...
Nikki Thuijs, Renske D. Steenbergen
exaly   +6 more sources

Premalignant epithelial disorders of the vulva: squamous vulvar intraepithelial neoplasia, vulvar Paget's disease and melanoma in situ

Acta Obstetricia Et Gynecologica Scandinavica, 2010
No standard screening programs exist to detect vulvar carcinoma or its precursor lesions, and therefore gynecologists, dermatologists and other healthcare providers in this field should be aware of the clinical features, behavior and management of the ...
Marc van Beurden, Theo J M Helmerhorst, Leen J Blok   +2 more
exaly   +5 more sources